Whitehawk Therapeutics Inc
WHWKHealthcare|Biotechnology|US
$3.13
+0.11 (+3.64%)
Tangible Book / Share
$2.21
Cash / Share
$2.29
About
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Stock Price
+49.0%(1Y)
1M
-9.8%
3M
-34.2%
6M
-21.2%
YTD
+29.3%
1Y
+43.6%
3Y
-32.7%
5Y
-88.4%
Pipeline Summary
2 total trials2
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Recruiting: 2
Active Trials (2)
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
NCT07444814Endometrial Cancer
Phase 1Recruiting
Enrollment: 226 participants
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
NCT07470853PROC
Phase 1Recruiting
Enrollment: 265 participants
Key Facts
Market Cap$178.4M
Employees23 (-43% YoY)
CEODavid J. Lennon
IPO DateAug 1, 2017
Beta0.81
52-Week Range$1.97 – $5.5
Avg Volume384,602
ExchangeNASDAQ
Websiteir.whitehawktx.com
Ownership
Float41.5%
Shares Outstanding57.0M
Recent Insider Trades
Giacobello Scott M.AWARD
Sep 15, 2026118,476 shares @ $4.09
Giacobello Scott M.AWARD
Sep 15, 2026118,476 shares
BALL BRYANAWARD
Sep 15, 202691,633 shares @ $4.09
BALL BRYANAWARD
Sep 15, 202691,633 shares
Dornan DavidAWARD
Sep 15, 202685,887 shares @ $4.09
Peers
Recent News
Surrozen (NASDAQ:SRZN) & Whitehawk Therapeutics (NASDAQ:WHWK) Financial Comparison
Oct 12, 2026 · defenseworld.net
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Stock Has Consensus Target Price of $8.33 According to Brokerages
Oct 8, 2026 · defenseworld.net
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
Oct 1, 2026 · prnewswire.com
Analysts Set Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Price Target at $8.20
Sep 16, 2026 · defenseworld.net
Whitehawk Therapeutics, Inc. (WHWK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Sep 15, 2026 · seekingalpha.com
Data last updated: Nov 9, 2026, 04:40 AM